E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/17/2012 in the Prospect News PIPE Daily.

Oncologix Tech sells $20,000 of common stock through private placement

Company places 1 million of its shares at $0.02 per share in offering

By Devika Patel

Knoxville, Tenn., Oct. 17 - Oncologix Tech Inc. completed a $20,000 private placement of stock on Oct. 16, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

The company sold 1 million common shares at $0.02 per share, which is a 33.33% discount to the Oct. 15 closing share price of $0.03.

The Grand Rapids, Mich., company has developed a brachytherapy device for the treatment of soft tissue cancer tumors in the liver.

Issuer:Oncologix Tech Inc.
Issue:Common stock
Amount:$20,000
Shares:1 million
Price:$0.02
Warrants:No
Settlement date:Oct. 16
Stock symbol:OTCBB: OCLG
Stock price:$0.03 at close Oct. 15

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.